Clinical trials for a llama antibody-based treatment for COVID-19 begin

Eliteinternet0222 Sep, 2022Business

Ghent's VIB-Urgent Center for Medical Biotechnology reports that Winter's antibodies mitigate the severity of coronavirus infections, both wild-type and variations. They have started Phase 1 studies of their medication based on the llama antibodies. She said that "at the moment we are not finding mutations of a high frequency anywhere near where the binding site is" when it comes to the very tiny goat anti-llama biotin antibodies that may bind to certain portions of the virus's protein spike